Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00281944 | Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors | completed | Phase 1 | 42 | National Cancer Institute (NCI)NIH | 1 | May 3, 2013 | clinicaltrials |
| NCT00287833 | Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Healthy Men | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | May 3, 2013 | clinicaltrials |
| NCT00348985 |
| PXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas |
| completed |
| Phase 1 |
| 55 |
| National Cancer Institute (NCI)NIH |
| 1 |
| May 3, 2013 |
| clinicaltrials |
| NCT01225536 | Dose Escalation Study of ARQ 736 in Adult Subjects With Advanced Solid Tumors Harboring BRAF and/or NRAS Mutations | completed | Phase 1 | 24 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 2 | May 3, 2013 | clinicaltrials |
| NCT01118611 | Aurora B/C Kinase Inhibitor GSK1070916A in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 38 | Cancer Research UKOTHER | 1 | May 1, 2013 | clinicaltrials |
| NCT00003425 | Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect | completed | Phase 1 / Phase 2 | 25 | University of KentuckyOTHER | 1 | Apr 26, 2013 | clinicaltrials |
| NCT00003403 | GPX-100 in Treating Patients With Solid Tumors | completed | Phase 1 | — | Gem PharmaceuticalsINDUSTRY | 1 | Apr 23, 2013 | clinicaltrials |
| NCT00660426 | Study Of Advanced Gastrointestinal Malignancies And Other Solid Tumors | completed | Phase 1 | 30 | Washington University School of MedicineOTHER | 1 | Apr 23, 2013 | clinicaltrials |
| NCT00420485 | Dose-escalation Study of Gimatecan Administered in Two Different Schedules in Adult Patients With Advanced Solid Tumors | completed | Phase 1 | 120 | Novartis PharmaceuticalsINDUSTRY | 7 | Apr 19, 2013 | clinicaltrials |
| NCT00003109 | Irinotecan Plus Raltitrexed in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 39 | Fox Chase Cancer CenterOTHER | 1 | Apr 17, 2013 | clinicaltrials |
| NCT00021346 | Carboplatin and Gemcitabine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 8 | Fox Chase Cancer CenterOTHER | 1 | Apr 17, 2013 | clinicaltrials |
| NCT00003207 | Liposomal Doxorubicin and PSC 833 in Treating Patients With AIDS-Related Kaposi's Sarcoma or Other Advanced Cancers | completed | Phase 1 | 14 | Washington University School of MedicineOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00089362 | Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00938574 | Study With Atu027 in Patients With Advanced Solid Cancer | completed | Phase 1 | 34 | Silence Therapeutics GmbHINDUSTRY | 1 | Apr 9, 2013 | clinicaltrials |
| NCT00003925 | Combination Chemotherapy In Treating Patients With Advanced Cancer | completed | Phase 1 | 36 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 8, 2013 | clinicaltrials |
| NCT00253565 | Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 25 | Herbert HurwitzOTHER | 1 | Apr 8, 2013 | clinicaltrials |
| NCT00586092 | A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tumors | completed | Phase 1 | 45 | Herbert HurwitzOTHER | 1 | Apr 8, 2013 | clinicaltrials |
| NCT00016185 | Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT00024284 | Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors | completed | Phase 1 | — | Bristol-Myers SquibbINDUSTRY | 2 | Apr 5, 2013 | clinicaltrials |
| NCT00003956 | Combination Chemotherapy in Treating Patients With Advanced Cancer | completed | Phase 1 | 25 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT00429234 | Gemcitabine and Dasatinib in Advanced Solid Tumors | completed | Phase 1 | 54 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT00084643 | GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Mar 27, 2013 | clinicaltrials |
| NCT00003406 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer | completed | Phase 1 / Phase 2 | 30 | Cancer Treatment Centers of AmericaOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00003703 | Chemotherapy in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Jewish General HospitalOTHER | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00022295 | Phenoxodiol in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | 36 | Kazia Therapeutics LimitedINDUSTRY | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00091052 | Radiation Therapy and Sargramostim in Treating Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | — | Sirius MedicineINDUSTRY | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00834704 | Safety Study of PEGPH20 Given to Patients With Advanced Solid Tumors(PEG) | completed | Phase 1 | 14 | Halozyme TherapeuticsINDUSTRY | 1 | Mar 26, 2013 | clinicaltrials |
| NCT00016354 | Benzoylphenylurea in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 19 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Mar 25, 2013 | clinicaltrials |
| NCT00084812 | Safingol and Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 43 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 22, 2013 | clinicaltrials |
| NCT00003368 | Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Mar 21, 2013 | clinicaltrials |
| NCT00303797 | Sorafenib and Bortezomib in Treating Patients With Advanced Cancer | completed | Phase 1 | 50 | National Cancer Institute (NCI)NIH | 1 | Mar 19, 2013 | clinicaltrials |
| NCT00014248 | Adenosine Triphosphate in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Mar 18, 2013 | clinicaltrials |
| NCT00996957 | Study of ACE-041 in Patients With Advanced Solid Tumors or Relapsed/Refractory Multiple Myeloma | completed | Phase 1 | 37 | Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USAINDUSTRY | 1 | Mar 18, 2013 | clinicaltrials |
| NCT01806376 | A Phase I Study of Subutinib Maleate Capsules on Toleration and Pharmacokinetics | unknown | Phase 1 | 20 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Mar 8, 2013 | clinicaltrials |
| NCT00007917 | Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 58 | National Cancer Institute (NCI)NIH | 1 | Feb 28, 2013 | clinicaltrials |
| NCT01800812 | Effects of OM-174 in Adult Patients With Solid Tumors(OM-174) | completed | Phase 1 | 27 | Centre Hospitalier Universitaire DijonOTHER | 0 | Feb 28, 2013 | clinicaltrials |
| NCT00529022 | Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer | completed | Phase 1 | 36 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00823524 | Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer | completed | Phase 1 / Phase 2 | 47 | Asan Medical CenterOTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00002980 | Decitabine in Treating Patients With Melanoma or Other Advanced Cancer | completed | Phase 1 | — | California Cancer ConsortiumNETWORK | 1 | Feb 15, 2013 | clinicaltrials |
| NCT00544284 | Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment | completed | Phase 1 | 25 | City of Hope Medical CenterOTHER | 1 | Feb 15, 2013 | clinicaltrials |
| NCT01101412 | Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Feb 15, 2013 | clinicaltrials |
| NCT00500422 | Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients | completed | Phase 1 | 134 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT00428545 | Bevacizumab and Bortezomib in Patients With Advanced Malignancy | completed | Phase 1 | 104 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 12, 2013 | clinicaltrials |
| NCT00955812 | STAT3 Inhibitor for Solid Tumors | completed | Phase 1 | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 12, 2013 | clinicaltrials |
| NCT00002862 | Perillyl Alcohol in Treating Patients With Refractory Cancer | completed | Phase 1 | 25 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00002946 | Penclomedine in Treating Patients With Solid Tumors or Lymphoma | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00003330 | Interleukin-12 in Treating Patients With Advanced Cancer | completed | Phase 1 | 54 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00004189 | Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00004229 | Endostatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
| NCT00004242 | Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Feb 11, 2013 | clinicaltrials |
Data updated 23 days agoSource updated May 3, 2013source: clinicaltrials